Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19012 | 459 | 32.4 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
299 | 17980 | ANNONACEOUS ACETOGENINS//PRINS CYCLIZATION//ACETOGENINS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ERIBULIN MESYLATE | Author keyword | 56 | 89% | 5% | 25 |
2 | ERIBULIN | Author keyword | 23 | 55% | 6% | 29 |
3 | HALICHONDRIN B | Author keyword | 15 | 68% | 3% | 13 |
4 | E7389 | Author keyword | 13 | 80% | 2% | 8 |
5 | HALAVEN | Author keyword | 8 | 100% | 1% | 5 |
6 | MICROTUBULE DYNAMICS INHIBITOR | Author keyword | 8 | 100% | 1% | 5 |
7 | BISELIDES | Author keyword | 6 | 100% | 1% | 4 |
8 | POLYETHER MACROLIDE | Author keyword | 5 | 54% | 2% | 7 |
9 | FR177391 | Author keyword | 4 | 75% | 1% | 3 |
10 | NOZAKI HIYAMA REACTION | Author keyword | 4 | 56% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ERIBULIN MESYLATE | 56 | 89% | 5% | 25 | Search ERIBULIN+MESYLATE | Search ERIBULIN+MESYLATE |
2 | ERIBULIN | 23 | 55% | 6% | 29 | Search ERIBULIN | Search ERIBULIN |
3 | HALICHONDRIN B | 15 | 68% | 3% | 13 | Search HALICHONDRIN+B | Search HALICHONDRIN+B |
4 | E7389 | 13 | 80% | 2% | 8 | Search E7389 | Search E7389 |
5 | HALAVEN | 8 | 100% | 1% | 5 | Search HALAVEN | Search HALAVEN |
6 | MICROTUBULE DYNAMICS INHIBITOR | 8 | 100% | 1% | 5 | Search MICROTUBULE+DYNAMICS+INHIBITOR | Search MICROTUBULE+DYNAMICS+INHIBITOR |
7 | BISELIDES | 6 | 100% | 1% | 4 | Search BISELIDES | Search BISELIDES |
8 | POLYETHER MACROLIDE | 5 | 54% | 2% | 7 | Search POLYETHER+MACROLIDE | Search POLYETHER+MACROLIDE |
9 | FR177391 | 4 | 75% | 1% | 3 | Search FR177391 | Search FR177391 |
10 | NOZAKI HIYAMA REACTION | 4 | 56% | 1% | 5 | Search NOZAKI+HIYAMA+REACTION | Search NOZAKI+HIYAMA+REACTION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | E7389 | 87 | 86% | 10% | 44 |
2 | ORGANOCHROMIUM REAGENTS | 49 | 94% | 4% | 17 |
3 | HALICHONDRIN B ANALOG | 48 | 71% | 8% | 39 |
4 | SPONGE LISSODENDORYX SP | 38 | 93% | 3% | 14 |
5 | MESYLATE E7389 | 33 | 100% | 3% | 13 |
6 | MACROCYCLIC KETONE ANALOGS | 27 | 72% | 5% | 21 |
7 | ANTITUMOR POLYETHER MACROLIDE | 27 | 74% | 4% | 20 |
8 | NORHALICHONDRIN B | 26 | 80% | 3% | 16 |
9 | NIII CRII MEDIATED COUPLING REACTION | 25 | 63% | 5% | 25 |
10 | HALICHONDRIN B | 21 | 39% | 10% | 44 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Eribulin for the Treatment of Advanced or Metastatic Breast Cancer: A NICE Single Technology Appraisal | 2015 | 3 | 4 | 50% |
From micrograms to grams: scale-up synthesis of eribulin mesylate | 2013 | 19 | 12 | 75% |
The development of the asymmetric Nozaki-Hiyama-Knishi reaction | 2007 | 69 | 43 | 86% |
Eribulin Mesylate (E7389): Review of Efficacy and Tolerability in Breast, Pancreatic, Head and Neck, and Non-Small Cell Lung Cancer | 2012 | 4 | 4 | 100% |
The Halichondrins and E7389 | 2009 | 46 | 105 | 60% |
Case History: Discovery of Eribulin (HALAVEN (TM)), a Halichondrin B Analogue That Prolongs Overall Survival in Patients with Metastatic Breast Cancer | 2011 | 8 | 11 | 91% |
Eribulin-A review of preclinical and clinical studies | 2012 | 10 | 39 | 49% |
Carbon-carbon bond formations involving organochromium(III) reagents | 1999 | 395 | 326 | 21% |
Effectiveness and safety of eribulin mesylate: a new therapeutic option in the treatment of metastatic breast cancer | 2012 | 2 | 17 | 82% |
Eribulin for Advanced Breast Cancer: A Drug Evaluation | 2013 | 1 | 20 | 85% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SYNTH BIOORGANUMR 7175 | 1 | 100% | 0.4% | 2 |
2 | SYNTH BIOORGAN | 1 | 11% | 2.2% | 10 |
3 | SYNTH BIO ORGAN | 1 | 40% | 0.4% | 2 |
4 | EISAI PROD CREAT SYST | 1 | 11% | 1.5% | 7 |
5 | BIOPHARMACEUT ASSESSMENTS | 1 | 50% | 0.2% | 1 |
6 | INOVA THORAC ONCOL PROGRAM | 1 | 50% | 0.2% | 1 |
7 | PHARMLC 1 | 1 | 50% | 0.2% | 1 |
8 | SYNTH BIOORGANLCI | 1 | 50% | 0.2% | 1 |
9 | UMR 7175 SYNTH BIOORGAN | 1 | 50% | 0.2% | 1 |
10 | ONCOL PROD CREAT UNIT | 1 | 29% | 0.4% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000129890 | ETHYL TRIBROMOACETATE//HEXABROMOACETONE//ACID BROMIDE |
2 | 0.0000102550 | EPOTHILONES//EPOTHILONE//IXABEPILONE |
3 | 0.0000102286 | ALLYLATION//HOMOALLYLIC ALCOHOLS//HOMOALLYLIC ALCOHOL |
4 | 0.0000095778 | LOW VALENT TITANIUM//PINACOL COUPLING//PINACOL |
5 | 0.0000095202 | DOLASTATIN 10//DIDEMNIN B//TZT 1027 |
6 | 0.0000083454 | RICE FALSE SMUT//USTILAGINOIDEA VIRENS//RHIZOXIN |
7 | 0.0000083363 | REFORMATSKY REACTION//ASYMMETRIC REFORMATSKY REACTION//CHIRAL AMINOALCOHOLS |
8 | 0.0000083217 | APLYRONINE A//THEONELLA SWINHOEI//BISTRAMIDE A |
9 | 0.0000077889 | AMPHIDINIUM SP//AMPHIDINOL//AMPHIDINOLIDES |
10 | 0.0000074759 | DIMETAL//TITANOCENEII//CARBONYL OLEFINATION |